Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Rheumatoid Arthritis Drugs Global Market Report 2025
Request Sample Buy Now
Global Rheumatoid Arthritis Drugs Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Rheumatoid Arthritis Drugs Global Market Report 2025

By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types), By Route Of Administration (Oral, Parenteral, Topical, Other Route Of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Rheumatoid Arthritis Drugs Market Overview

• Rheumatoid Arthritis Drugs market size has reached to $60.3 billion in 2024

• Expected to grow to $65.34 billion in 2029 at a compound annual growth rate (CAGR) of 2.1%

• Growth Driver: Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs

• Market Trend: Growth In The Rheumatoid Arthritis Drug Market With Introduces To Address Disease Activity

• North America was the largest region and fastest growing region.

What Is Covered Under Rheumatoid Arthritis Drugs Market?

Rheumatoid arthritis drugs refer to drugs given for the treatment of an autoimmune disease, which has symptoms like inflammation of the tissues around the joints. These medications minimize permanent harm to the joints and other tissues while slowing the progression of rheumatoid arthritis.

The main types of rheumatoid arthritis drugs are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), biologic response modifiers (BRMs) and other drug types. Nonsteroidal anti-inflammatory drugs (NSAIDs) refer to a class of drugs that are used to treat inflammation, fever, and other inflammatory conditions. It avoids many of the adverse effects of steroids. The different route of administration include oral, parenteral, topical and other route of administration. The rheumatoid arthritis drugs distribution channels include hospital pharmacy, retail pharmacy and online pharmacy.

Rheumatoid Arthritis Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Rheumatoid Arthritis Drugs Market Size 2025 And Growth Rate?

The rheumatoid arthritis drugs market size has grown marginally in recent years. It will grow from$60.3 billion in 2024 to $60.1 billion in 2025 at a compound annual growth rate (CAGR) of 2.1%. The growth in the historic period can be attributed to increasing disease prevalence, healthcare infrastructure growth, awareness and education initiatives, government initiatives and support, strategic collaborations

What Is The Rheumatoid Arthritis Drugs Market Growth Forecast?

The rheumatoid arthritis drugs market size is expected to see steady growth in the next few years. It will grow to $65.34 billion in 2029 at a compound annual growth rate (CAGR) of nan%. The growth in the forecast period can be attributed to personalized medicine trends, emerging markets growth, pipeline development, focus on combination therapies, increasing healthcare expenditure. Major trends in the forecast period include biological therapies dominance, biosimilars impact, personalized medicine advances, oral therapies growth, focus on early diagnosis and intervention.

The forecast of 2.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. rheumatology clinics by driving up the cost of janus kinase inhibitor and biologic disease-modifying antirheumatic drugs sourced from the UK and India, exacerbating autoimmune disease treatment costs and increasing specialty pharmacy burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Rheumatoid Arthritis Drugs Market Segmented?

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types

2) By Route Of Administration: Oral, Parenteral, Topical, Other Route Of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Indomethacin

2) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone

3) By Disease-Modifying Antirheumatic Drugs: Methotrexate, Sulfasalazine, hydroxychloroquine, Leflunomide

4) By Biologic Response Modifiers: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, B-cell Inhibitors

5) By Other Drug Types: Janus Kinase Inhibitors, Other Novel Therapies

What Is Driving The Rheumatoid Arthritis Drugs Market? Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs

The growing cases of arthritis is expected to propel the growth of the rheumatoid arthritis drugs market going forward. Rheumatoid arthritis refers to an autoimmune and inflammatory condition where the immune system knowingly harms healthy cells in the body, leading to inflammation (painful swelling) in the body areas affected. Rheumatoid arthritis drugs and self-management techniques are readily available to treat RA effectively. The drugs reduce pain, enhance joint flexibility, and inhibit the spread of disease. For instance, February 2024, according to the National Center for Health Statistics, a US-based government agency In 2022, the age-adjusted prevalence of diagnosed arthritis in adults was 18.9%, with women (21.5%) more likely to be affected than men (16.1%). The prevalence rose significantly with age, from 3.6% in adults aged 18–34 to 53.9% in those aged 75 and older. Therefore, growing cases of arthritis is expected to drive the rheumatoid arthritis drug industry.

What Is Driving The Rheumatoid Arthritis Drugs Market? Rising Elderly Population Fuels Expansion Of The Rheumatoid Arthritis Drugs Market

The growing elderly population is expected to propel the growth of the rheumatoid arthritis drugs market going forward. The elderly population refers to the ratio defined as the proportion of people 65 years of age and above to people who are working age, which is defined as 18 to 64 years old. Elderly individuals pose both challenges and opportunities in managing rheumatoid arthritis (RA). The newer drugs like JAK inhibitors and targeted synthetic DMARDs offer alternative options with potentially better safety profiles for some elderly patients. For instance, in July 2022, according to ReliefWeb, a US-based humanitarian information portal, the global population of people aged 65 or older is expected to increase from 10% in 2022 to 16% in 2050. Further, this population is expected to grow to 94 million by 2050, accounting for 23% of the total population. Therefore, the growing elderly population is driving the growth of the rheumatoid arthritis drugs industry.

Who Are The Major Players In The Global Rheumatoid Arthritis Drugs Market?

Major companies operating in the rheumatoid arthritis drugs market include Pfizer Inc., Abbvie Inc., Amgen Inc., Novartis AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, F-Hoffmann La Roche AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Merck & Co Inc., Johnson & Johnson Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A, Biogen Inc., Regeneron Pharmaceuticals Inc., Galapagos NV, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, UCB S.A., Astellas Pharma Inc., Corbus Pharmaceuticals Holdings Inc., Roche Holding AG, Daiichi Sankyo Company Limited, Mallinckrodt Pharmaceuticals, Gilead Sciences Inc.

What Are The Key Trends Of The Global Rheumatoid Arthritis Drugs Market? Growth In The Rheumatoid Arthritis Drug Market With Introduces To Address Disease Activity

Product innovations are a key trend gaining popularity in the rheumatoid arthritis drug market. Companies operating in the rheumatoid arthritis drugs market are adopting new product launches to sustain their position in the market. For instance, in August 2022, R-Pharm, a Russian private high-tech pharmaceutical company, launched Olokizumab, which is a humanized monoclonal antibody that specifically attacks the cytokine interleukin-6. This messenger molecule has a role in the advancement of joint destruction in rheumatoid arthritis and, like TNF (tumor necrosis factor), triggers inflammatory responses in the body, which lowers the disease activity in many rheumatoid arthritis patients.

What Are The Key Trends Of The Global Rheumatoid Arthritis Drugs Market? Innovative Solutions In The Rheumatoid Arthritis Drug Market

Major companies operating in the rheumatoid arthritis drug market are focused on developing innovations, such as subcutaneous injection, to gain a competitive edge in the market. A subcutaneous injection, also known as a sub-q or SQ injection, is a common way to deliver medication just beneath the skin. For instance, in November 2022, Eisai Co Ltd., a Japan-based pharmaceutical company, and Nippon Medac Co Ltd., a Tokyo-based pharmaceutical company, launched the Metoject Subcutaneous Injection Syringe. It is the first self-administrable prefilled syringe formulation of methotrexate (MTX) for rheumatoid arthritis (RA) approved in Japan. The Metoject Subcutaneous Injection Syringe is prefilled with a single dose of MTX and features a thin, 27-gauge needle for a more comfortable injection experience. It is also designed for easy self-administration, with a clear injection window and a simple plunger mechanism.

Need data on a specific region in this market?
Request Customisation

Rheumatoid Arthritis Drugs Market Merger And Acquisition: Amgen Bolsters Inflammation Portfolio With Acquisition Of Horizon Therapeutic

In October 2023, Amgen PLC, a US-based biotechnology company, acquired Horizon Therapeutic Plc for $27.8 billion. This acquisition strengthens Amgen’s inflammation portfolio by adding first-in-class, early-in-lifecycle medicines to treat rare inflammatory diseases. Horizon Therapeutic PLC, is an Ireland-based biopharmaceutical company that provides treatments for focal segmental glomerulosclerosis, kidney transplant rejection, and rheumatoid arthritis drugs.

Regional Analysis For The Global Rheumatoid Arthritis Drugs Market

North America was the largest region in the rheumatoid arthritis drugs market in 2024.North America is expected to be the fastest-growing region in the global rheumatoid arthritis market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Rheumatoid Arthritis Drugs Market?

The rheumatoid arthritis drugs market consists of sales of products like abatacept, aceclofenac and adalimumab. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rheumatoid Arthritis Drugs Industry?

The rheumatoid arthritis drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rheumatoid arthritis drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Rheumatoid Arthritis Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $60.1 billion
Revenue Forecast In 2034 $65.34 billion
Growth Rate CAGR of % from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types
2) By Route Of Administration: Oral, Parenteral, Topical, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments: 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Indomethacin
2) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone
3) By Disease-Modifying Antirheumatic Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide
4) By Biologic Response Modifiers: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, B-cell Inhibitors
5) By Other Drug Types: Janus Kinase Inhibitors, Other Novel Therapies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Abbvie Inc., Amgen Inc., Novartis AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, F-Hoffmann La Roche AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Merck & Co Inc., Johnson & Johnson Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A, Biogen Inc., Regeneron Pharmaceuticals Inc., Galapagos NV, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, UCB S.A., Astellas Pharma Inc., Corbus Pharmaceuticals Holdings Inc., Roche Holding AG, Daiichi Sankyo Company Limited, Mallinckrodt Pharmaceuticals, Gilead Sciences Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Rheumatoid Arthritis Drugs Market Characteristics

3. Rheumatoid Arthritis Drugs Market Trends And Strategies

4. Rheumatoid Arthritis Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rheumatoid Arthritis Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Rheumatoid Arthritis Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Rheumatoid Arthritis Drugs Market Growth Rate Analysis

5.4. Global Rheumatoid Arthritis Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Rheumatoid Arthritis Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Rheumatoid Arthritis Drugs Total Addressable Market (TAM)

6. Rheumatoid Arthritis Drugs Market Segmentation

6.1. Global Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Corticosteroids

Disease-Modifying Antirheumatic Drugs (DMARDs)

Biologic Response Modifiers (BRMs)

Other Drug Types

6.2. Global Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Topical

Other Route Of Administrations

6.3. Global Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

6.4. Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ibuprofen

Naproxen

Diclofenac

Indomethacin

6.5. Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prednisone

Methylprednisolone

Dexamethasone

6.6. Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Methotrexate

Sulfasalazine

Hydroxychloroquine

Leflunomide

6.7. Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Biologic Response Modifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tumor Necrosis Factor (TNF) Inhibitors

Interleukin Inhibitors

B-cell Inhibitors

6.8. Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Janus Kinase Inhibitors

Other Novel Therapies

7. Rheumatoid Arthritis Drugs Market Regional And Country Analysis

7.1. Global Rheumatoid Arthritis Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Rheumatoid Arthritis Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rheumatoid Arthritis Drugs Market

8.1. Asia-Pacific Rheumatoid Arthritis Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rheumatoid Arthritis Drugs Market

9.1. China Rheumatoid Arthritis Drugs Market Overview

9.2. China Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rheumatoid Arthritis Drugs Market

10.1. India Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rheumatoid Arthritis Drugs Market

11.1. Japan Rheumatoid Arthritis Drugs Market Overview

11.2. Japan Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rheumatoid Arthritis Drugs Market

12.1. Australia Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rheumatoid Arthritis Drugs Market

13.1. Indonesia Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rheumatoid Arthritis Drugs Market

14.1. South Korea Rheumatoid Arthritis Drugs Market Overview

14.2. South Korea Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rheumatoid Arthritis Drugs Market

15.1. Western Europe Rheumatoid Arthritis Drugs Market Overview

15.2. Western Europe Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rheumatoid Arthritis Drugs Market

16.1. UK Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rheumatoid Arthritis Drugs Market

17.1. Germany Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rheumatoid Arthritis Drugs Market

18.1. France Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rheumatoid Arthritis Drugs Market

19.1. Italy Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rheumatoid Arthritis Drugs Market

20.1. Spain Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rheumatoid Arthritis Drugs Market

21.1. Eastern Europe Rheumatoid Arthritis Drugs Market Overview

21.2. Eastern Europe Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rheumatoid Arthritis Drugs Market

22.1. Russia Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rheumatoid Arthritis Drugs Market

23.1. North America Rheumatoid Arthritis Drugs Market Overview

23.2. North America Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rheumatoid Arthritis Drugs Market

24.1. USA Rheumatoid Arthritis Drugs Market Overview

24.2. USA Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rheumatoid Arthritis Drugs Market

25.1. Canada Rheumatoid Arthritis Drugs Market Overview

25.2. Canada Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rheumatoid Arthritis Drugs Market

26.1. South America Rheumatoid Arthritis Drugs Market Overview

26.2. South America Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rheumatoid Arthritis Drugs Market

27.1. Brazil Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rheumatoid Arthritis Drugs Market

28.1. Middle East Rheumatoid Arthritis Drugs Market Overview

28.2. Middle East Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rheumatoid Arthritis Drugs Market

29.1. Africa Rheumatoid Arthritis Drugs Market Overview

29.2. Africa Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rheumatoid Arthritis Drugs Market Competitive Landscape And Company Profiles

30.1. Rheumatoid Arthritis Drugs Market Competitive Landscape

30.2. Rheumatoid Arthritis Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Rheumatoid Arthritis Drugs Market Other Major And Innovative Companies

31.1. Eli Lilly and Company

31.2. F. Hoffmann-La Roche AG

31.3. Bristol-Myers Squibb Company

31.4. AstraZeneca PLC

31.5. Merck & Co., Inc.

31.6. Johnson & Johnson Inc.

31.7. Bayer AG

31.8. Teva Pharmaceuticals Industries Ltd.

31.9. Sun Pharmaceutical Industries Ltd.

31.10. Sanofi S.A.

31.11. Biogen Inc.

31.12. Regeneron Pharmaceuticals Inc.

31.13. Galapagos NV

31.14. Abbott Laboratories

31.15. Takeda Pharmaceutical Company Limited

32. Global Rheumatoid Arthritis Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rheumatoid Arthritis Drugs Market

34. Recent Developments In The Rheumatoid Arthritis Drugs Market

35. Rheumatoid Arthritis Drugs Market High Potential Countries, Segments and Strategies

35.1 Rheumatoid Arthritis Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Rheumatoid Arthritis Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Rheumatoid Arthritis Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

Need tailored insights? Customise this report to fit your business goals.

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Biologic Response Modifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Rheumatoid Arthritis Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Rheumatoid Arthritis Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Amgen Inc. Financial Performance
  • Table 82: Novartis AG Financial Performance
  • Table 83: Boehringer Ingelheim International GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Biologic Response Modifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Rheumatoid Arthritis Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Rheumatoid Arthritis Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Rheumatoid Arthritis Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Rheumatoid Arthritis Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Rheumatoid Arthritis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Rheumatoid Arthritis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Amgen Inc. Financial Performance
  • Figure 82: Novartis AG Financial Performance
  • Figure 83: Boehringer Ingelheim International GmbH Financial Performance

Global Non Hodgkin Lymphoma (NHL) Market Landscape: Trends and Market Share to 2029

Read More About Global Non Hodgkin Lymphoma (NHL) Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Non-Opioid Pain Patch Industry Through 2029

Read More About Competitive and Market Trend Analysis of Non-Opioid Pain Patch Industry Through 2029

Industry Trends Show Occupational Medicines Market Set to Expand at 6.6% CAGR Until 2029

Read More About Industry Trends Show Occupational Medicines Market Set to Expand at 6.6% CAGR Until 2029

Strategic Report on Olanzapine Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Olanzapine Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

View Report

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

View Report

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

View Report

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

View Report

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

View Report

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

View Report

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

View Report

Frequently Asked Questions

Rheumatoid arthritis drugs refer to drugs given for the treatment of an autoimmune disease, which has symptoms like inflammation of the tissues around the joints. These medications minimize permanent harm to the joints and other tissues while slowing the progression of rheumatoid arthritis. For further insights on this market, request a sample here

The market major growth driver - Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs. For further insights on this market, request a sample here

The rheumatoid arthritis drugs market size has declined marginally in recent years. It will grow from " $60.3 billion in 2024 to $60.1 billion in 2025 at a compound annual growth rate (CAGR) of -0.3%. The growth in the historic period can be attributed to increasing disease prevalence, healthcare infrastructure growth, awareness and education initiatives, government initiatives and support, strategic collaborations The rheumatoid arthritis drugs market size is expected to see steady growth in the next few years. It will grow to " $65.34 billion in 2029 at a compound annual growth rate (CAGR) of 2.1%. The growth in the forecast period can be attributed to personalized medicine trends, emerging markets growth, pipeline development, focus on combination therapies, increasing healthcare expenditure. Major trends in the forecast period include biological therapies dominance, biosimilars impact, personalized medicine advances, oral therapies growth, focus on early diagnosis and intervention. For further insights on this market, request a sample here

The rheumatoid arthritis drugs market covered in this report is segmented –
1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types
2) By Route Of Administration: Oral, Parenteral, Topical, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Indomethacin
2) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone
3) By Disease-Modifying Antirheumatic Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide
4) By Biologic Response Modifiers: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, B-cell Inhibitors
5) By Other Drug Types: Janus Kinase Inhibitors, Other Novel Therapies For further insights on this market, request a sample here

North America was the largest region in the rheumatoid arthritis drugs market in 2024.North America is expected to be the fastest-growing region in the global rheumatoid arthritis market report during the forecast period. The regions covered in the rheumatoid arthritis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the rheumatoid arthritis drugs market include Pfizer Inc., Abbvie Inc., Amgen Inc., Novartis AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, F-Hoffmann La Roche AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Merck & Co Inc., Johnson & Johnson Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A, Biogen Inc., Regeneron Pharmaceuticals Inc., Galapagos NV, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, UCB S.A., Astellas Pharma Inc., Corbus Pharmaceuticals Holdings Inc., Roche Holding AG, Daiichi Sankyo Company Limited, Mallinckrodt Pharmaceuticals, Gilead Sciences Inc. . For further insights on this market, request a sample here.

Major trends in this market include Growth In The Rheumatoid Arthritis Drug Market With Introduces To Address Disease Activity. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Rheumatoid Arthritis Drugs Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top
\
Back to top